Company Overview

Omada Health, Inc. is a digital health company focused on the prevention and management of chronic conditions through evidence-based, technology-enabled care programs. The company operates in the digital therapeutics, virtual care, and chronic disease management segments of the healthcare industry, serving employers, health plans, and health systems seeking to reduce long-term medical costs and improve population health outcomes.

Omada’s primary offerings center on structured lifestyle change programs addressing type 2 diabetes, prediabetes, hypertension, and musculoskeletal (MSK) conditions, delivered through a combination of digital platforms, connected devices, and human coaching. The company positions itself as a clinically validated provider with outcomes supported by peer-reviewed research and long-term engagement metrics. Founded in 2011, Omada evolved from an initial diabetes prevention focus into a broader chronic care platform as employer-sponsored digital health adoption expanded and value-based care models gained traction.

Business Operations

Omada Health generates revenue primarily through recurring per-member-per-month fees paid by employers, health plans, and government-sponsored programs, with pricing tied to enrollment and, in some arrangements, performance outcomes. Its core operating segments include Omada for Diabetes, Omada for Hypertension, Omada for MSK, and integrated cardiometabolic care programs, all delivered via the company’s proprietary digital platform.

Operations are predominantly U.S.-based, with nationwide program delivery supported by a distributed workforce of health coaches, clinicians, and support staff. Omada controls its core software platform, data analytics capabilities, and program design, while leveraging third-party manufacturers for connected devices such as wireless scales and blood pressure monitors. The company has established partnerships with major national health plans and large self-insured employers, though specific commercial terms are not publicly disclosed.

Strategic Position & Investments

Omada’s strategic direction emphasizes expansion into comprehensive cardiometabolic care, deeper integration with payer care management workflows, and increased use of data analytics to demonstrate long-term clinical and financial outcomes. Growth initiatives have focused on cross-selling additional condition programs to existing clients and aligning offerings with value-based reimbursement models.

The company has completed targeted acquisitions to broaden its clinical scope, most notably the acquisition of Physera, which strengthened Omada’s musculoskeletal care capabilities and enabled the launch of Omada for MSK as an integrated offering. Omada has also invested in clinical research and outcomes validation to differentiate itself from less-regulated wellness applications. Data regarding additional minority investments or joint ventures is inconclusive based on available public sources.

Geographic Footprint

Omada Health is headquartered in San Francisco, California, with operational reach across the United States through virtual delivery rather than physical clinics. Its programs are accessible nationwide to eligible members of employer-sponsored and health plan populations, making geographic scalability a core element of its business model.

While the company’s primary commercial focus remains the U.S. healthcare market, Omada has explored limited international research collaborations. However, sustained revenue-generating operations outside North America have not been consistently documented in public disclosures, and international expansion remains limited based on available verified information.

Leadership & Governance

Omada Health was co-founded by Sean Duffy, who has played a central role in shaping the company’s mission around evidence-based digital care. The leadership team emphasizes clinical rigor, long-term engagement, and alignment with payer and employer economics rather than direct-to-consumer growth. Governance is supported by a board that includes healthcare, technology, and investment professionals.

Key executives include:

• Sean Duffy – Co-Founder and Chief Executive Officer
• Adrian James – President
• Wei-Li Shao – Chief Financial Officer
• Dr. Jennifer McClure – Chief Science Officer
• Katherine Morgan – Chief Operating Officer

Leadership strategy centers on scaling clinically validated programs, maintaining regulatory credibility, and positioning Omada as a long-term partner in chronic disease cost management rather than a standalone digital wellness vendor.